G
Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
NSE:GLS
Price:
836.25 INR
0.63%
Market Closed
Updated:
Jun 1, 2024
Glenmark Life Sciences Ltd
Additional Paid In Capital
|
Glenmark Life Sciences Ltd
Additional Paid In Capital Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Additional Paid In Capital
₹10B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Glenmark Life Sciences Ltd's Additional Paid In Capital?
Additional Paid In Capital
10B
INR
10B
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Additional Paid In Capital amounts to 10B INR.
What is Glenmark Life Sciences Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 1Y
0%
0%
Over the last year, the Additional Paid In Capital growth was 0%.
You don't have any saved screeners yet
